The MedicX Fund Limited Extraordinary General Meeting results (5596Q)
September 12 2017 - 12:25PM
UK Regulatory
TIDMMXF
RNS Number : 5596Q
The MedicX Fund Limited
12 September 2017
Press Release
For immediate release
12 September 2017
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Extraordinary General Meeting results
The Board of MedicX Fund Limited (LSE: MXF), is pleased to
announce that at the Extraordinary General Meeting of its
Shareholders held at 4.30 p.m. today, the special resolution
proposing that the Company becomes resident in the United Kingdom
for tax purposes and enters the UK REIT regime, was duly passed.
The details of the resolution were as follows:
It was resolved that the Proposals (as defined in the Company's
circular to shareholders dated 18 August 2017) be approved and that
with effect from 00.01a.m. on 29 September 2017, the new articles
of incorporation of the Company produced to the meeting containing
amendments required for the purposes of the Company's entry into
the UK REIT regime be adopted.
In Favour - 178,223,806 (99.92%)
Against - 138,078 (0.08%)
Withheld - Nil
David Staples, Chairman of MedicX Fund, commented:
"We are delighted that the Fund's shareholders have strongly
supported the Company's proposal to convert to a UK REIT. Entry
into the UK REIT regime will benefit our shareholders by exempting
future profits from the Company's Qualifying Property Rental
Business from UK corporation tax. REIT status is the next step in
the Company's growth journey which will also potentially widen the
appeal to new investors."
Notes:
-- The votes "in favour" of the resolution are calculated as the
aggregate of proxy instructions voting "in favour" of the
resolution and the votes at the Chairman's discretion.
-- A vote "withheld" is not a vote in law and is not calculated
in the proportion of the votes "in favour" or "against" the
resolution.
-- The total number of voting rights as at the proxy deadline was 428,530,249.
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
Octopus Healthcare Group +44 (0) 20 3142 4820
Mike Adams, Chief Executive Officer
Canaccord Genuity
Andrew Zychowski/Helen Goldsmith +44 (0) 20 7523 8000
Buchanan +44 (0) 20 7466 5000
Charles Ryland/Vicky Hayns
Information on MedicX Fund Limited
MedicX Fund Limited (the "Fund" or the "Company", or together
with its subsidiaries, the "Group") is the specialist primary care
infrastructure investor in modern, purpose-built primary healthcare
properties in the United Kingdom and Ireland, listed on the London
Stock Exchange, with a portfolio comprising 156 properties.
The Investment Adviser to the Company is Octopus Healthcare
Adviser Ltd, which is part of the Octopus Healthcare group. Octopus
Healthcare invests in and develops properties as well as creating
partnerships to deliver innovative healthcare buildings to improve
the health, wealth and wellbeing of the UK. It currently manages
over GBP1.1 billion of healthcare investments across a number of
platforms, with a focus on five core areas: GP surgeries, care
homes, special education schools, retirement housing and private
hospitals. Octopus Healthcare is part of the Octopus group, a
fast-growing UK fund management business with leading positions in
several specialist sectors including healthcare property, energy,
property finance and smaller company investing. Octopus manages
GBP7 billion of funds for more than 50,000 retail and institutional
investors as well as supplying energy to more than 100,000
customers.
Octopus Healthcare Adviser Ltd is authorised and regulated by
the Financial Conduct Authority.
The Company's website address is www.medicxfund.com. Neither the
contents of the Company's website nor the contents of any website
accessible from hyperlinks on the Company's website (or any other
website), nor the contents of any website accessible from
hyperlinks within this announcement, are incorporated into, or
forms part of, this announcement.
The Company's Legal Entity Identifier is
2138008POF35FTNFCB25.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ROMBLGDCDDBBGRD
(END) Dow Jones Newswires
September 12, 2017 12:25 ET (16:25 GMT)
Medicx (LSE:MXF)
Historical Stock Chart
From Apr 2024 to May 2024
Medicx (LSE:MXF)
Historical Stock Chart
From May 2023 to May 2024